Prev Close | 221.61 |
Open | 219.21 |
Day Low/High | 214.88 / 219.69 |
52 Wk Low/High | 206.60 / 369.69 |
Volume | 1.45M |
Prev Close | 221.61 |
Open | 219.21 |
Day Low/High | 214.88 / 219.69 |
52 Wk Low/High | 206.60 / 369.69 |
Volume | 1.45M |
Exchange | NASDAQ |
Shares Outstanding | 358.96B |
Market Cap | 78.64B |
P/E Ratio | 84.36 |
Div & Yield | N.A. (N.A) |
We saw it fill the pre-earnings gap, and now it is digesting some of that volatility from the past few days. Intuitive Surgical (ISRG) was a wild ride last night. We saw it fill the pre-earnings gap, and now it is digesting some of that volatility f...
I have set up trades in CHKP and URI.
These solid names are all set to report this week.
It's certainly what's in vogue at the moment, but the data may surprise you.
Instead, refocus on the dividend plays and circle back to the names that have done well.
Contributor Ken Shreve takes a look at economic data and earnings reports scheduled for the week of July 16.
If there's a silver lining to former leaders struggling, it's that new leadership often arises in their place.
Alexion Pharmaceuticals and Intuitive Surgical are leaders in a top-performing sector.
These stocks -- all short-term trades -- are on the rise after they took too much of a beating.
Apple's results move the stock after hours, but recent leaders come out worse for wear.
The action in the market is now very stock-specific.
This is a good chance to buy growth stocks that have done well at a discount.
The stock market has picked up its pace in tandem with earnings season.
Instead of the Dow earnings, look at the results of ISRG and URI.
Contributor Ken Shreve takes a look at economic data and earnings scheduled for the coming week, including reports from Intuitive Surgical and Qualcomm.
You don't want to be in these shares right now.
It may not be long before these three stocks join the $1,000 club.
Start reviewing and evaluating your performance in the first quarter.
These names are widely misunderstood, and that certainly applies to this high-quality name.
Play the good action in individual stocks and don't worry about a big market shift.
Increased caution is warranted, but don't be overly bearish given this market's recent inclinations.
The virtuous cycle of overrunning price targets is in effect.
When the selling has run its course, the market will tell us which stocks to buy.
Most of the big performers could benefit from some do-nothing time.